Skip to main content
. Author manuscript; available in PMC: 2014 Aug 7.
Published in final edited form as: Am J Surg Pathol. 2011 May;35(5):678–686. doi: 10.1097/PAS.0b013e3182152629

Table 2.

Immunohistochemical Staining Results* for Metastatic Clear Cell Renal Cell Carcinoma versus Adrenal Cortical Lesion with Adrenocortical Markers

Calretinin (C, N) Inhibin (C) MelanA (C) SF-1 (N) Synaptophysin (C)
CC-RCC (overall) 18/184 (10%) 17/184 (9%) 18/184 (10%) 0/184 (0%) 3/184 (2%)
CC-RCC (WD) 13/133 (10%) 11/133 (8%) 11/133 (8%) 0/133 (0%) 2/133 (2%)
CC-RCC (PD) 5/51 (10%) 6/51 (12%) 7/51 (14%) 0/51 (0%) 1/51 (2%)
ACL 56/63 (89%) 54/63 (86%) 54/63 (86%) 54/63 (86%) 37/63 (59%)
*

≥2+ staining intensity considered positive

CC-RCC = metastatic clear cell renal cell carcinoma, WD = well-differentiated, PD = poorly-differentiated, ACL = adrenal cortical lesion, C = cytoplasmic, N = nuclear